SEARCH NEWS & VIEWS


New Painkillers Reduce Overdose Risk
High-Res Imaging Reveals How Cells ‘Take Out the Trash’
A Structural Clue to Attacking Malaria’s ‘Achilles Heel’
Potential New Autism Drug Shows Promise in Mice
Ozanimod Successful in Clinical Trials for Multiple Sclerosis
NEWS & VIEWS HOME
PAST ISSUES
KUDOS
SCIENTIFIC CALENDAR
CA AUDITORIUM EVENTS
CONTACT

FOLLOW US
1
New Painkillers Reduce Overdose Risk

The Bohn Lab questions whether pain relief can come without dangerous side effects.

High-Res Imaging Reveals How Cells ‘Take Out the Trash’

New study offers clues to developing treatments for Alzheimer’s and other diseases.

A Structural Clue to Attacking Malaria’s ‘Achilles Heel’

TSRI and PATH collaboration provides blueprint for design of a next-generation vaccine.

Potential New Autism Drug Shows Promise in Mice

The Lipton Lab aims to restore an electrical signaling imbalance in the brain.

Ozanimod Successful in Clinical Trials for Multiple Sclerosis

TSRI-invented drug successful in phase 3 clinical trials.

  • How Flu Shot Manufacturing Forces Influenza to Mutate
  • “Missing Link” in Chemistry That Led to Life on Earth
  • New Research Opens the Door to ‘Functional Cure’ for HIV
  • ‘Double Decker’ Antibody Technology Fights Cancer
  • HIVE Center Receives $27 Million in NIGMS Funding to Advance HIV Research
  • Keary Engle Named TSRI Outstanding Mentor for 2017
  • TSRI Study Reveals New Clues to How a Successful HIV Vaccine Could Work
  • Calibr and TSRI Executive Matt Tremblay Receives Biocom Catalyst Award
  • TSRI Scientist Wins Prestigious Young Investigator Award
  • TSRI Chemists Develop Inexpensive, Versatile Technique for Making RNA